Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
Alexander Egeberg, Kyoungah See, Alyssa Garrelts, et al.
BMC Dermatology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 69

Showing 51-75 of 69 citing articles:

Psoriatic onychodystrophy: Clinical course, diagnosis and therapeutic aspects
А. В. Таганов, А. В. Молочков, Natalya G. Kulikova, et al.
Russian Journal of Skin and Venereal Diseases (2023) Vol. 26, Iss. 6, pp. 575-596
Open Access | Times Cited: 1
Higher prevalence of nail psoriasis in patients with psoriatic arthritis receiving biologic therapy: A single center cross sectional study
Natsumi Ikumi, Koremasa Hayama, Noboru Kitamura, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 8
Closed Access
A Prospective, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of a Cream Containing Xyloglucan, Pea Protein, and
Stefano Veraldi, Valentina Rosca, Remus Orăsan, et al.
PubMed (2024) Vol. 17, Iss. 3, pp. 12-17
Closed Access
Trial of Topical Tacrolimus by Two Different Concentrations in Treatment of Nail Psoriasis: Randomized Comparative Study
Salma Alattar, Sherif Ismail, Abdel-Raheim Fayed
The Egyptian Journal of Hospital Medicine (2024) Vol. 95, Iss. 1, pp. 1795-1800
Open Access
Characterization of psoriasis patients in special body areas: real-world evidence from the Chinese Psoriasis Standardized Diagnosis and Treatment Center
Yuge Gao, Chao Li, Meng Tong, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access
Guselkumab - In Psoriasis and Beyond
Aditya Kumar Bubna, Vinayak Viplav
Dermatology Practical & Conceptual (2024), pp. e2024181-e2024181
Open Access
Epidemiology and clinical features of psoriasis in hard-to-treat body locations: A Chinese nationwide population-based study
Lingyi Lu, Lu Cao, Fan Jiang, et al.
Research Square (Research Square) (2024)
Open Access
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy (2024)
Open Access
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
Xia Li, Yangfeng Ding, Chunlei Zhang, et al.
Advances in Therapy (2024)
Closed Access
Caracterización clínica, sociodemográfica, farmacológica y calidad de vida de pacientes con diagnóstico de psoriasis moderada a severa atendidos en una clínica especializada en psoriasis
Carolina Mesa, María Paulina Estrada, Elsa María Vásquez Trespalacios, et al.
CES Medicina (2022) Vol. 36, Iss. 1, pp. 17-29
Open Access | Times Cited: 2
NEW ONSET OF NAIL PSORIASIS AFTER MRNA COVID-19 VACCINE: A CASE REPORT
Klimentina Gospodinova, Dimitar Gospodinov
Journal of IMAB - Annual Proceeding (Scientific Papers) (2022) Vol. 28, Iss. 1, pp. 4289-4291
Open Access | Times Cited: 2
Psoriasis of the Nails
Hira Muneer, Sadia Masood
(2020)
Closed Access | Times Cited: 1
Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review
Ronald Vender, Irina Turchin, Perla Lansang, et al.
JAAD International (2022) Vol. 8, pp. 60-63
Open Access | Times Cited: 1
Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis
Jason E. Hawkes, Kyoungah See, Russel Burge, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 4, pp. 1107-1118
Open Access | Times Cited: 1
Psoriasis in areas difficult to treat and biological therapy
Anna Lis‐Święty, Aleksandra Frątczak
Dermatology Review (2021) Vol. 108, Iss. 3, pp. 171-177
Open Access | Times Cited: 1
Diagnosis of Psoriasis in Hard-To-Treat Body Locations
Dan Vâță
Biomedical Journal of Scientific & Technical Research (2021) Vol. 37, Iss. 3
Open Access | Times Cited: 1
Psoriasis patient preferences for the use of biologics during the coronavirus era
Yayoi Tada, Asako Itakura, Kumiko Hosono, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 5, pp. 596-607
Open Access
Facial psoriasis in the etiology of prolonged erythema following medium‐depth chemical peels for severe photodamage
Liang Joo Leow, Nicolas Zubrzycki
Journal of Cosmetic Dermatology (2023) Vol. 22, Iss. 5, pp. 1554-1559
Open Access
Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis
Sotirios G. Tsiogkas, Eleni K. Karamitrou, Maria G. Grammatikopoulou, et al.
Current Medical Research and Opinion (2023) Vol. 40, Iss. 2, pp. 155-163
Closed Access
Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis
Amirmansoor Gholami, Ahmad Vafaeian, Maryam Daneshpazhooh, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access
Previous Page - Page 3

Scroll to top